BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 4995735)

  • 1. Kinetics of the vaccinia virus plaque neutralization test.
    O'Brien TC; Myers MG; Tauraso NM
    Appl Microbiol; 1971 May; 21(5):968-70. PubMed ID: 4995735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Enhancement of neutralization of vaccinia virus by antiglobulin].
    Weeke-Lüttmann M
    Arch Gesamte Virusforsch; 1970; 31(1):28-32. PubMed ID: 5312165
    [No Abstract]   [Full Text] [Related]  

  • 3. Vaccinia virus strain differences. I. Neutralization of vaccinia virus strains by homologous and heterologous antisera.
    Dunlap RC; Barker LF
    Arch Gesamte Virusforsch; 1973; 42(2):107-16. PubMed ID: 4126981
    [No Abstract]   [Full Text] [Related]  

  • 4. Vaccinia virus: kinetics of the hemagglutination-inhibition test and preparation of hemagglutinin.
    O'Brien TC; Tauraso NM
    Arch Gesamte Virusforsch; 1972; 36(1):158-65. PubMed ID: 4622262
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of the immunofluorescent-cell counting and plaque methods for the assay of vaccinia virus.
    Ibrahim AL; Loh PC
    Appl Microbiol; 1972 Feb; 23(2):214-7. PubMed ID: 4622819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of the virus-serum incubation period upon vaccinia virus serum neutralization titers.
    Katz JB
    J Biol Stand; 1987 Oct; 15(4):389-92. PubMed ID: 3680308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Study of the kinetics of neutralization of the vaccina virus by means of titration of the homologous antiserum.
    Rapicetta M; Mancini G; Santoro R
    Boll Ist Sieroter Milan; 1973; 52(4):315-20. PubMed ID: 4798236
    [No Abstract]   [Full Text] [Related]  

  • 8. Heat-labile accessory factor involved in vaccinia virus plaque neutralization.
    O'Brien TC; Hannah JE; Tauraso NM
    Arch Gesamte Virusforsch; 1973; 40(3):366-74. PubMed ID: 4735532
    [No Abstract]   [Full Text] [Related]  

  • 9. Characteristics of a new poxvirus isolated from Indian buffaloes.
    Baxby D; Hill BJ
    Arch Gesamte Virusforsch; 1971; 35(1):70-9. PubMed ID: 4331778
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies on the early antigens induced by vaccinia virus.
    Ueda Y; Tagaya I; Amano H; Ito M
    Virology; 1972 Sep; 49(3):794-800. PubMed ID: 4627344
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of heat-labile factors on the neutralization of vaccinia virus by human.
    Takabayashi K; McIntosh K
    Infect Immun; 1973 Oct; 8(4):582-9. PubMed ID: 4200542
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralization assay using a modified vaccinia virus Ankara vector expressing the green fluorescent protein is a high-throughput method to monitor the humoral immune response against vaccinia virus.
    Cosma A; Bühler S; Nagaraj R; Staib C; Hammarin AL; Wahren B; Goebel FD; Erfle V; Sutter G
    Clin Diagn Lab Immunol; 2004 Mar; 11(2):406-10. PubMed ID: 15013995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Herpesvirus neutralization: induction of the persistent fraction by insufficient antibody.
    Wallis C; Melnick JL
    Virology; 1970 Sep; 42(1):128-37. PubMed ID: 4990056
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on different strains of vaccinia virus with particular reference to their quality regarding immunogenicity and reactogenicity. 3. Studies in rabbits and monkeys (Macaca mulatta).
    Sehgal CL; Suri NK; Choudhury S; Murty DK; Raghavan NG
    Indian J Med Res; 1973 Sep; 61(9):1265-74. PubMed ID: 4205143
    [No Abstract]   [Full Text] [Related]  

  • 15. Accuracy and repeatability of a micro plaque reduction neutralization test for vaccinia antibodies.
    Borges MB; Kato SE; Damaso CR; Moussatché N; da Silva Freire M; Lambert Passos SR; do Nascimento JP
    Biologicals; 2008 Mar; 36(2):105-10. PubMed ID: 17892944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specific macrophage immunity to vaccinia virus: macrophage-virus interaction.
    Avila FR; Schultz RM; Tompkins WA
    Infect Immun; 1972 Jul; 6(1):9-16. PubMed ID: 4564156
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serological relationship of buffalopox virus to vaccinia and cowpox viruses.
    Kataria RS; Singh IP
    Acta Virol; 1970 Jul; 14(4):307-11. PubMed ID: 4394186
    [No Abstract]   [Full Text] [Related]  

  • 18. Radioisotope precipitation tests with 14 C and 51 Cr labeled vaccinia antigens.
    Felsenfeld O; Dutta NK; Felsenfeld AD; Brannon RB
    Proc Soc Exp Biol Med; 1971 Oct; 138(1):149-51. PubMed ID: 5001503
    [No Abstract]   [Full Text] [Related]  

  • 19. The adsorption kinetics of vaccinia virus: demonstration of reversible adsorption (elution).
    Greenham LW; Collins MA; Smithson W
    Microbios; 1973; 7(26):103-15. PubMed ID: 4799060
    [No Abstract]   [Full Text] [Related]  

  • 20. A tetrazolium-based colorimetric assay for titration of neutralizing antibodies against vaccinia virus.
    Ifrah M; Stienlauf S; Shoresh M; Katz E
    Viral Immunol; 1998; 11(1):49-54. PubMed ID: 9586697
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.